Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04956978 · ClinicalTrials.gov registry record · NA

Shared Decision Making to Address Racial Disparities in Oral Anticoagulation in NVAF

A NA study, sponsored by Duke University.

Not yet
Registry status
NA
Development phase
40
Enrollment target

NCT04956978 is a NA study that has not yet begun recruiting, run by Duke University. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04956978, a NA study, has not yet begun recruiting, sponsored by Duke University.

NOT YET RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The study is a pilot analysis using a decision on the risk and benefits of oral anticoagulation for stroke reduction for patients with non-valvular atrial fibrillation. This study is a feasibility and acceptability analysis but will also measure preliminary effectiveness measures. The investigator hypothesizes that a patient decision support tool will increase decision quality and secondarily increase the use of oral anticoagulation in Black patients with non-valvular atrial fibrillation.

Interventions

  • OTHER Patient Decision Support Tool

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-06-01
Est. Completion 2026-12-31
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT04956978

The ClinicalTrials.gov registry entry for NCT04956978 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Patient Decision Support Tool is the first listed.

NCT04956978 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04956978 about?

NCT04956978 is a clinical study titled "Shared Decision Making to Address Racial Disparities in Oral Anticoagulation in NVAF". The study is a pilot analysis using a decision on the risk and benefits of oral anticoagulation for stroke reduction for patients with non-valvular atrial fibrillation. This study is a feasibility and acceptability analysis but will also measure preliminary effectiveness measures. The investigator ...

What is the current status of trial NCT04956978?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-06-01. Estimated completion is 2026-12-31.

What interventions are being tested in trial NCT04956978?

The interventions under investigation include: Patient Decision Support Tool (OTHER).

Who is sponsoring clinical trial NCT04956978?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.